Proving that the continuous-flow devices get people to transplant is a good first step, but it doesn't say that this is a lifetime therapy or a durable support therapy for longer than a few months.

A continuous-flow left ventricular assist device (LVAD) improved survival free from disabling stroke compared with a pulsatile LVAD, when used as destination therapy over a 2-year period in patients ...

In patients with advanced HF, mechanical unloading of the failing myocardium using pulsatile-flow devices is more effective vs. using continuous-flow devices, according to study results. Researchers ...

The study involved 7 children weighing 8 kg to 30 kg; all children survived, 5 to transplant and 1 to recovery. HealthDay News — The Jarvik 2015 left ventricular assist device (LVAD) seems promising ...

Angiotensin II antagonists may help prevent GI bleeding among heart failure patients with continuous-flow left ventricular assist devices (LVADs), a retrospective study suggested. Taking ACE ...

The use of mechanical support of the circulation with ventricular assist devices for refractory heart failure is increasing. This is due to expanding indications, including for acute heart failure and ...

LAS VEGAS — Patients with elevated central venous pressure shortly after implantation with a continuous-flow left ventricular assist device were at increased risk for gastrointestinal bleeding in a ...

The newer HeartMate 3 continuous-flow left ventricular assist device (LVAD) improved on its predecessor in staving off neurological complications among implanted patients, long-term results from the ...

A 61-year-old man in cardiogenic shock was recently transferred to our hospital. Angiography revealed total occlusion of the left anterior descending coronary artery and an 80% ostial stenosis of the ...

Type of flow of ventricular devices has been an important factor that positively influenced the adoption rates. Initially, instruments with pulsatile flow type have been launched, however, they were ...